4.3 Article

Neprilysin and Insulin-Degrading Enzyme Levels Are Increased in Alzheimer Disease in Relation to Disease Severity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pathology

Neprilysin: An enzyme candidate to slow the progression of Alzheimer's disease

Salim S. El-Amouri et al.

AMERICAN JOURNAL OF PATHOLOGY (2008)

Review Clinical Neurology

A beta-degrading enzymes in Alzheimer's disease

James Scott Miners et al.

BRAIN PATHOLOGY (2008)

Review Pharmacology & Pharmacy

The role of the cell surface LRP and soluble LRP in blood-brain barrier a clearance in Alzheimer's Disease

R. Deane et al.

CURRENT PHARMACEUTICAL DESIGN (2008)

Article Biochemical Research Methods

Immunocapture-based fluorometric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenates

James Scott Miners et al.

JOURNAL OF NEUROSCIENCE METHODS (2008)

Article Geriatrics & Gerontology

Age-dependent decline of neprilysin in Alzheimer's disease and normal brain:: Inverse correlation with Aβ levels

E. Hellstrom-Lindahl et al.

NEUROBIOLOGY OF AGING (2008)

Article Biochemistry & Molecular Biology

The GSK3 hypothesis of Alzheimer's disease

Claudie Hooper et al.

JOURNAL OF NEUROCHEMISTRY (2008)

Article Neurosciences

Neprilysin protects neurons against Aβ peptide toxicity

Salim S. El-Amouri et al.

BRAIN RESEARCH (2007)

Article Biochemistry & Molecular Biology

Regulation of steady-state β-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme

Elizabeth A. Eckman et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Clinical Neurology

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy

James Scott Miners et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)

Article Clinical Neurology

Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic Tg2576 mice with Alzheimer pathology

Maria C. Leal et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)

Article Biochemistry & Molecular Biology

Neprylisin decreases uniformly in Alzheimer's disease and in normal aging

R Russo et al.

FEBS LETTERS (2005)

Article Clinical Neurology

Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's disease

M Maruyama et al.

ANNALS OF NEUROLOGY (2005)

Article Biochemistry & Molecular Biology

Somatostatin regulates brain amyloid β peptide Aβ42 through modulation of proteolytic degradation

T Saito et al.

NATURE MEDICINE (2005)

Article Multidisciplinary Sciences

Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo

BC Miller et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Multidisciplinary Sciences

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

W Farris et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Biochemistry & Molecular Biology

α- and β-secretase:: profound changes in Alzheimer's disease

SJ Tyler et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)

Article Clinical Neurology

Declining expression of neprilysin in Alzheimer disease vasculature: Possible involvement in cerebral amyloid angiopathy

M Carpentier et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)

Article Biochemistry & Molecular Biology

β-amyloid catabolism:: roles for neprilysin (NEP) and other metallopeptidases?

JA Carson et al.

JOURNAL OF NEUROCHEMISTRY (2002)

Article Multidisciplinary Sciences

Metabolic regulation of brain Aβ by neprilysin

N Iwata et al.

SCIENCE (2001)

Article Biochemistry & Molecular Biology

Tissue plasminogen activator requires plasminogen to modulate amyloid-β neurotoxicity and deposition

HM Tucker et al.

JOURNAL OF NEUROCHEMISTRY (2000)